Health services and systems: latest news

Health services and systems resources

Health services and systems features

Health services and systems in your own words

  • Going into hospital

    My experiences of hospitalisation are mixed. I’ve been admitted twice in the last six months, both times for a minor operation. However, following the excellent...

    From: In your own words

Health services and systems news from aidsmap

More news

Health services and systems news selected from other sources

  • Analysis reveals extent of drug industry funding of UK patient organisations

    The researchers call for greater transparency to ensure that industry funding is not unduly influenced by commercial objectives.

    23 May 2019 | The BMJ press release
  • Medicare decides against tighter management of HIV drugs

    The Department of Health and Human Services will continue barring Medicare Part D plans from applying the drug utilization management tools prior authorization and step therapy for beneficiaries taking HIV antiretroviral drugs. A rule proposed in November 2018 would have permitted such practices. Gilead voiced opposition to the original proposal, saying physicians need to have the flexibility to prescribe the right medicines for patients.

    21 May 2019 | BioPharma Dive
  • Gilead struck anti-competitive deals to bolster profits on an HIV drug, lawsuit says

    In a bid to maintain its dominance in the HIV market, Gilead Sciences (GILD) allegedly conspired with other drug makers whose medicines were part of a so-called combination cocktail in order to block generic competition, according to a lawsuit filed by AIDS activists and two unions.

    15 May 2019 | STAT
  • What Can the United States Learn from Africa about HIV Epidemic Control?

    In a highly relevant new commentary just published in the New England Journal of Medicine, Wafaa M. El-Sadr, ICAP global director, with co-authors Kenneth H. Mayer, Miriam Rabkin, and Sally Hodder, explore the state of AIDS in America, the barriers that stand in the way of ending this persistent public health threat, and, compellingly, propose strategies and tactics that can be adopted from the progress made toward epidemic control in sub-Saharan Africa to bring HIV under control in the U.S.

    02 May 2019 | ICAP
  • In Ethiopia, A Focus on Multi-Month ART Scripting at Scale Pays Off

    As ministries of health and their partners move to scale up differentiated service delivery (DSD) for HIV treatment, one approach is taking the spotlight. Multi-month scripting (MMS) is a facility-based, individual-focused DSD model, in which recipients of care who are doing well on antiretroviral therapy (ART) receive larger amounts of ART at each visit, enabling their appointments to be spaced at longer intervals. In many countries, MMS is combined with appointment spacing and fast-track approaches to minimize the amount of time that people living with HIV need to spend at health facilities.

    26 April 2019 | ICAP
  • Thousands feared at risk after Mexico reforms HIV+ regime

    Thousands of Mexicans living with HIV or at risk of infection could be left without life-saving services after the government changed the way it funds treatment, according to public health experts and LGBT+ rights advocates.

    18 April 2019 | Reuters
  • Long-Acting HIV Treatment Is Coming. Our Health Care System Needs to Prepare

    New conversations are starting in HIV care as phase III trials have shown that monthly injections of cabotegravir and rilpivirine (Edurant) are non-inferior to a three-drug pill regimen. In 2018, TheBody asked a range of people living with HIV about their willingness to switch to an injectible, and most had mixed feelings. But even if there's widespread interest in this new way of taking antiretroviral therapy (and most likely also prevention, not too far away), it's important to consider not just the willingness of people to move to this new form of treatment, but whether health care systems and providers in the U.S. are ready to support this innovation.

    16 April 2019 | The Body Pro
  • Venezuela Falls Under The Triple Attack of HIV, Tuberculosis And Malaria

    A little over a year later, the situation is a lot more serious than we originally foresaw. Every health, poverty, nutrition, economic growth and social development index in Venezuela has loudly worsened, while the Venezuelan government keeps on denying not only the existence of the humanitarian crisis affecting the country but even worse, the entrance of humanitarian aid.

    16 April 2019 | Caracas Chronicles
  • US: How HHS Secretary Alex Azar Reconciles Medicaid Cuts With Stopping The Spread Of HIV

    In his State of the Union address this year, President Trump announced an initiative "to eliminate the HIV epidemic in the United States within 10 years." The man who pitched the president on this idea is Alex Azar, the Secretary of the Department of Health and Human Services.

    09 April 2019 | NPR
  • Taxpayers funded this HIV research. The government patented it. Now a company profits.

    Thomas Folks spent years in his U.S. Centers for Disease Control and Prevention lab developing a treatment to block deadly HIV in monkeys. Then, San Francisco AIDS researcher Robert Grant, using $50 million in federal grants, proved the treatment worked in people who engaged in risky sex. Their work — almost fully funded by U.S. taxpayers — created a new use for an older prescription drug called Truvada: preventing HIV infection. But the U.S. government, which patented the treatment in 2015, is not receiving a penny for that use of the drug from Gilead Sciences Inc., Truvada’s maker, which racked up $3 billion in Truvada sales last year.

    29 March 2019 | Los Angeles Times
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.